Sort
51,593 grants matching “hepatitis”
Evaluating HBVZ10-Based Therapies for cccDNA Clearance: Virological Foundation and Synergistic Combinations
$606,178Yong-Yuan Zhang · Hbvtech · N43 · FY2025 · AI
Insulin sensitivity and fatty acid partitioning in skeletal muscle after exercise
$606,166Jeffrey F Horowitz · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Phenylbutyrate therapy for maple syrup urine disease
$606,154Brendan Hl Lee · Baylor College Of Medicine · R01 · FY2015 · DK
Lipid transport, oxidation and toxicity in the retina
$606,134Ignacio R Rodriguez · National Eye Institute · ZIA · FY2014 · EY
Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV
$606,133Robert A Schnoll · University Of Pennsylvania · R01 · FY2023 · CA
Cyanobacteria, cyanotoxins, and liver cancer development
$606,096Brenda Y Hernandez · University Of Hawaii At Manoa · U01 · FY2025 · CA
Developing a dynamic modeling framework for surveillance, prediction, and real-time resource allocation to improve health outcomes during infectious disease outbreaks
$606,013Lior Rennert · Clemson University · R01 · FY2025 · LM
Vaccine and Treatment Evaluation Unit at Saint Louis University
$606,000Daniel F. Hoft · Saint Louis University · UM1 · FY2020 · AI
Enhanced Anti-HIV-1 Antibody Responses in African American Women Seropositive for
$605,983Phillip Berman · University Of California Santa Cruz · R01 · FY2014 · DA
Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH).â
$605,950Elana Simon Rosenthal · University Of Maryland Baltimore · R01 · FY2025 · DA
MOLECULAR BEACONS FOR RETROVIRAL DIAGNOSTICS
$605,912Public Health Research Institute · R01 · FY2003 · EB
Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma
$605,790Hsian-Rong Tseng · University Of California Los Angeles · R01 · FY2020 · CA
Social determinants of fatty liver disease and its racial/ethnic disparities: The Multi-Ethnic Study of Atherosclerosis
$605,785Mariana Lazo Elizondo · Drexel University · R01 · FY2024 · DK
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
$605,722David Fiellin · Yale University · U01 · FY2015 · AA
Technical Validation of MRI Biomarkers of Liver Fat
$605,675Claude B Sirlin · University Of California, San Diego · R01 · FY2011 · DK
Role of DGAT in Triacyglycerol Metabolism
$605,638Robert V Farese · J. David Gladstone Institutes · R01 · FY2011 · DK
Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy
$605,589Charles H Hinkin · Brentwood Biomedical Research Institute · R01 · FY2008 · MH
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
$605,577Keoki Williams · Henry Ford Health System · R01 · FY2021 · DK
TNF alpha and Recovery from Alcoholic Liver Injury
$605,543Anna Mae Elizabeth Diehl · Duke University · R01 · FY2025 · AA
Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy
$605,400Charles H Hinkin · Brentwood Biomedical Research Institute · R01 · FY2010 · MH
Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment
$605,394James S Duncan · Yale University · R01 · FY2019 · CA
Biological Mechanisms through which TMAO Promotes Atherosclerosis
$605,377Hooman Allayee · University Of Southern California · R01 · FY2022 · HL
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV
$605,317Victor Valcour · University Of California, San Francisco · R01 · FY2010 · NS
Candidate Genes Affecting Adolescent Metabolic Syndrome
$605,288Ahmed H Kissebah · Medical College Of Wisconsin · R01 · FY2009 · DK
Exploring herpesvirus exonucleases as potential antiviral targets
$605,273Sandra K Weller · University Of Connecticut Sch Of Med/Dnt · R56 · FY2023 · AI